RU2286147C2 - Карбаматы для применения для предотвращения или лечения биполярного расстройства - Google Patents

Карбаматы для применения для предотвращения или лечения биполярного расстройства Download PDF

Info

Publication number
RU2286147C2
RU2286147C2 RU2003128996/14A RU2003128996A RU2286147C2 RU 2286147 C2 RU2286147 C2 RU 2286147C2 RU 2003128996/14 A RU2003128996/14 A RU 2003128996/14A RU 2003128996 A RU2003128996 A RU 2003128996A RU 2286147 C2 RU2286147 C2 RU 2286147C2
Authority
RU
Russia
Prior art keywords
formula
enantiomer
bipolar disorder
predominates
bipolar
Prior art date
Application number
RU2003128996/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2003128996A (ru
Inventor
Карлос Р. ПЛАТА-САЛАМАН (US)
Карлос Р. Плата-Саламан
Бою ЗАО (US)
Бою ЗАО
Рой Э. ТУАЙМЭН (US)
Рой Э. ТУАЙМЭН
Йонг Моон ЧОЙ (US)
Йонг Моон Чой
Роберт ГОРДОН (US)
Роберт Гордон
Original Assignee
Орто-Макнейл Фармасьютикал, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орто-Макнейл Фармасьютикал, Инк. filed Critical Орто-Макнейл Фармасьютикал, Инк.
Publication of RU2003128996A publication Critical patent/RU2003128996A/ru
Application granted granted Critical
Publication of RU2286147C2 publication Critical patent/RU2286147C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2003128996/14A 2001-02-27 2002-02-21 Карбаматы для применения для предотвращения или лечения биполярного расстройства RU2286147C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27168001P 2001-02-27 2001-02-27
US60/271,680 2001-02-27
US10/081,606 2002-02-21
US10/081,606 US7122576B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (2)

Publication Number Publication Date
RU2003128996A RU2003128996A (ru) 2005-03-10
RU2286147C2 true RU2286147C2 (ru) 2006-10-27

Family

ID=26765743

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003128996/14A RU2286147C2 (ru) 2001-02-27 2002-02-21 Карбаматы для применения для предотвращения или лечения биполярного расстройства

Country Status (25)

Country Link
US (1) US7122576B2 (enExample)
EP (1) EP1368021B1 (enExample)
JP (1) JP4276839B2 (enExample)
KR (1) KR20030074849A (enExample)
CN (1) CN1250214C (enExample)
AT (1) ATE378046T1 (enExample)
AU (1) AU2002242226B2 (enExample)
BR (1) BR0207832A (enExample)
CA (1) CA2439292A1 (enExample)
CY (1) CY1107199T1 (enExample)
CZ (1) CZ296641B6 (enExample)
DE (1) DE60223506T2 (enExample)
DK (1) DK1368021T3 (enExample)
ES (1) ES2295320T3 (enExample)
HU (1) HUP0303261A3 (enExample)
IL (2) IL157589A0 (enExample)
MX (1) MXPA03007716A (enExample)
MY (1) MY133370A (enExample)
NO (1) NO20033799L (enExample)
NZ (1) NZ527989A (enExample)
PL (1) PL364640A1 (enExample)
PT (1) PT1368021E (enExample)
RS (1) RS50680B (enExample)
RU (1) RU2286147C2 (enExample)
WO (1) WO2002067924A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2774970C2 (ru) * 2016-12-14 2022-06-24 ЭсКей БАЙОФАРМАСЬЮТИКАЛЗ КО., ЛТД. Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1809273E (pt) * 2004-09-16 2010-05-10 Janssen Pharmaceutica Nv Utililização de 2-fenil-1,2-etanodiol-(di)carbamatos para tratamento de epileptogénese
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
CN101568362A (zh) * 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
CA2715760C (en) * 2008-02-21 2017-06-13 Mitsubishi Tanabe Pharma Corporation Solid preparation for oral administration of cariprazine hydrochloride
AU2009270823B2 (en) 2008-07-16 2014-07-17 Richter Gedeon Nyrt. Pharmaceutical formulations containing dopamine receptor ligands
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
CN110290788A (zh) * 2016-12-14 2019-09-27 爱思开生物制药株式会社 氨基甲酸酯化合物用于预防、缓解或治疗双相障碍的用途
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ЖАРИКОВ Н.М. и др. Психиатрия. - М.: Медицина, 2000, с.403-404. *
МОРОЗОВА М.А. Новые подходы к лечению депрессий при аффективных расстройствах биполярного типа. Психиатрия и психофармакотерапия. 2001, 3, №1. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2774970C2 (ru) * 2016-12-14 2022-06-24 ЭсКей БАЙОФАРМАСЬЮТИКАЛЗ КО., ЛТД. Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства

Also Published As

Publication number Publication date
US20020193433A1 (en) 2002-12-19
CN1250214C (zh) 2006-04-12
JP4276839B2 (ja) 2009-06-10
CZ296641B6 (cs) 2006-05-17
DK1368021T3 (da) 2008-02-11
DE60223506D1 (de) 2007-12-27
NO20033799L (no) 2003-09-10
ATE378046T1 (de) 2007-11-15
US7122576B2 (en) 2006-10-17
BR0207832A (pt) 2004-06-22
RU2003128996A (ru) 2005-03-10
EP1368021B1 (en) 2007-11-14
ES2295320T3 (es) 2008-04-16
IL157589A (en) 2009-09-22
YU68003A (sh) 2006-08-17
CA2439292A1 (en) 2002-09-06
NZ527989A (en) 2005-12-23
MXPA03007716A (es) 2004-11-12
NO20033799D0 (no) 2003-08-26
EP1368021A1 (en) 2003-12-10
KR20030074849A (ko) 2003-09-19
HUP0303261A2 (hu) 2004-01-28
DE60223506T2 (de) 2008-09-18
PT1368021E (pt) 2007-12-19
HK1058762A1 (en) 2004-06-04
RS50680B (sr) 2010-06-30
JP2004525905A (ja) 2004-08-26
CZ20032312A3 (cs) 2004-06-16
CN1503666A (zh) 2004-06-09
WO2002067924A1 (en) 2002-09-06
AU2002242226B2 (en) 2006-06-29
CY1107199T1 (el) 2012-11-21
HUP0303261A3 (en) 2012-07-30
MY133370A (en) 2007-11-30
PL364640A1 (en) 2004-12-13
IL157589A0 (en) 2004-03-28

Similar Documents

Publication Publication Date Title
RU2300372C2 (ru) Карбаматы для применения для предотвращения или лечения биполярного расстройства
RU2294739C2 (ru) Производные карбамата для применения для предупреждения или лечения расстройств движений
US7122576B2 (en) Carbamate compounds for use in preventing or treating bipolar disorder
AU2002242226A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
KR100792814B1 (ko) 신경병증 통증 및 군발성 및 편두통성 두통-관련 통증의예방 또는 치료를 위해 사용하기 위한 카바메이트 화합물
AU2002354909B2 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2002255580B2 (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1058762B (en) Carbamate compounds for use in preventing or treating bipolar disorder
AU2002255580A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1063436B (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1063288B (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130222